Freitag Gregory Gene
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Freitag Gregory Gene. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PDSB | Purchase | 15,060 | $1.66 | $25,000 | Feb 28, 2025 | |
| AXGN | Option Exercise | 11,904 | — | — | Jun 4, 2024 | |
| AXGN | Sale | 25,000 | $9.00 | $225,000 | Mar 7, 2024 | |
| AXGN | Option Exercise | 6,459 | — | — | Jun 1, 2023 | |
| AXGN | Sale | 4,640 | $9.26 | $42,966 | May 23, 2023 | |
| AXGN | Sale | 13,000 | $12.74 | $165,620 | Nov 14, 2022 | |
| AXGN | Sale | 13,000 | $12.50 | $162,500 | Nov 8, 2022 | |
| AXGN | Sale | 8,886 | $9.70 | $86,194 | Aug 10, 2022 | |
| AXGN | Sale | 24,000 | $10.64 | $255,360 | Aug 8, 2022 | |
| AXGN | Option Exercise | 83,000 | $3.38 | $280,540 | Jul 25, 2022 | |
| AXGN | Option Exercise | 3,036 | — | — | Jun 1, 2022 | |
| AXGN | Option Exercise | 9,250 | $19.17 | $177,323 | Jun 17, 2021 | |
| PDSB | Purchase | 5,882 | $8.50 | $49,997 | Jun 15, 2021 | |
| AXGN | Option Exercise | 24,000 | $3.67 | $88,080 | Jun 4, 2021 | |
| AXGN | Option Exercise | 15,000 | $5.45 | $81,750 | May 26, 2021 | |
| AXGN | Sale | 24,000 | $22.06 | $529,440 | Feb 25, 2021 | |
| AXGN | Award / Grant | 1,784 | — | — | Feb 17, 2021 | |
| AXGN | Sale | 916 | $17.81 | $16,314 | Dec 27, 2020 | |
| AXGN | Sale | 379 | $16.42 | $6,223 | Dec 18, 2020 | |
| AXGN | Option Exercise | 13,046 | $3.67 | $47,879 | Sep 15, 2020 | |
| AXGN | General Counsel | Option Exercise | 125,000 | $3.50 | $437,500 | May 29, 2020 |
| AXGN | General Counsel | Tax Withholding | 1,002 | $14.68 | $14,709 | Feb 18, 2020 |
| PDSB | Award / Grant | 38,400 | $1.30 | $49,920 | Feb 14, 2020 | |
| AXGN | General Counsel | Award / Grant | 1,850 | — | — | Dec 18, 2019 |
| AXGN | General Counsel | Award / Grant | 3,377 | $17.57 | $59,334 | Feb 15, 2019 |
| AXGN | General Counsel | Sale | 45,000 | $33.00 | $1,485,000 | Nov 30, 2018 |
| AXGN | General Counsel | Sale | 20,000 | $32.25 | $645,000 | Nov 15, 2018 |
| AXGN | General Counsel & SVP BD | Option Exercise | 15,000 | $4.81 | $72,150 | Mar 21, 2018 |
| AXGN | General Counsel & SVP BD | Option Exercise | 36,000 | $2.74 | $98,640 | Mar 1, 2018 |
| AXGN | General Counsel & SVP BD | Option Exercise | 10,000 | $2.74 | $27,400 | Sep 25, 2017 |
| AXGN | General Counsel & SVP BD | Tax Withholding | 3,785 | $16.65 | $63,020 | Aug 27, 2017 |
| AXGN | General Counsel & SVP BD | Option Exercise | 23,000 | $2.74 | $63,020 | Dec 30, 2016 |
| AXGN | General Counsel | Award / Grant | 4,800 | $2.75 | $13,200 | Feb 10, 2015 |
| AXGN | CFO | Purchase | 200 | $2.34 | $468 | Jun 2, 2014 |
| AXGN | CFO | Award / Grant | 6,250 | — | — | Jan 2, 2014 |
| AXGN | CFO | Purchase | 8,334 | $3.00 | $25,002 | Aug 14, 2013 |
| 0000830656 | Other | 4,385 | — | — | Apr 5, 2012 | |
| AXGN | CFO | Purchase | 9,318 | $2.40 | $22,363 | Dec 30, 2011 |
| AXGN | CFO | Purchase | 500 | $2.86 | $1,430 | Nov 22, 2011 |
| 0000830656 | C | 26,640 | $1.88 | $50,083 | Sep 30, 2011 | |
| 0000830656 | Award / Grant | 14,880 | — | — | Sep 2, 2011 |